Cargando…
SOX11 promotes invasive growth and ductal carcinoma in situ progression
Here, we show that SOX11, an embryonic mammary marker that is normally silent in postnatal breast cells, is expressed in many oestrogen receptor‐negative preinvasive ductal carcinoma in situ (DCIS) lesions. Mature mammary epithelial cells engineered to express SOX11 showed alterations in progenitor...
Autores principales: | Oliemuller, Erik, Kogata, Naoko, Bland, Philip, Kriplani, Divya, Daley, Frances, Haider, Syed, Shah, Vandna, Sawyer, Elinor J, Howard, Beatrice A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637904/ https://www.ncbi.nlm.nih.gov/pubmed/28707729 http://dx.doi.org/10.1002/path.4939 |
Ejemplares similares
-
Sox9 regulates cell state and activity of embryonic mouse mammary progenitor cells
por: Kogata, Naoko, et al.
Publicado: (2018) -
SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells
por: Oliemuller, Erik, et al.
Publicado: (2020) -
Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
por: Tsang, Siu Man, et al.
Publicado: (2021) -
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
por: Petridis, Christos, et al.
Publicado: (2019) -
A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
por: Domenici, Giacomo, et al.
Publicado: (2019)